Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl
The purpose of this guide is to provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids.
View Guide
Search for Trainings
PCSS has compiled modules, webinars, podcasts, videos, and other resources designed to enhance providers knowledge and skills in evidence-based treatment practices.
Start Learning
Discover the rewards of treating patients with Opioid Use Disorders
Learn More
Buprenorphine Quick Start Guide
SAMHSA has developed a Buprenorphine Quick Start Guide for practitioners looking to prescribe buprenorphine.
View Guide
A Call To Action For The Medical Community On The Need To Address Opioid Epidemic
Dr. Hillary Kunins, PCSS clinical expert discusses the opioid epidemic and the urgent need for primary care providers to begin treating OUD patients.
Watch Video
Previous
Next

Calendar of Events

Featured Events

Clinical Roundtable
June 6, 2023
Ready or Not Here Come Xylazine and the Nitazenes
Webinar
June 12, 2023
FAME Session 8: Stimulant Use Disorder
View 8 Hour MOUD Trainings
View PCSS Exchange Sessions

Latest News

SAMHSA
May 2, 2023

Learn About SAMHSA’s Behavioral Health Equity Challenge

We wanted to share this message from SAMHSA about its Behavioral Health Equity Challenge.
SAMHSA
March 31, 2023

SAMHSA Recommendations for Curricular Elements in Substance Use Disorders Training

SAMHSA provides information on how practitioners can meet the requirement.
White House, Washington
March 29, 2023

ONDCP: Dr. Gupta Applauds FDA Announcement to Make First Naloxone Product Available Over-the-Counter

From the Office of National Drug Control Policy: WASHINGTON, D.C. – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), issued a statement following the U.S. Food and Drug Administration (FDA) approval of the first nonprescription, “over-the-counter” (OTC) Naloxone nasal spray (Narcan). Naloxone – a medicine that can reverse an opioid-related overdose – has been shown to be a critical tool to prevent fatal overdoses and save lives.

PCSS. Educate. Train. Mentor.